Synonyms: CDP-323 | CDP323
Compound class:
Synthetic organic
Comment: Zaurategrast (CDP-323) is a small molecule inhibitor of α4-containing integrin complexes that was developed by Celltech [3]. It was intended as a new oral drug treatment for multiple sclerosis [2]. Zaurategrast has the same mechanism of action as the approved MS therapeutic natalizumab. Zaurategrast is an ester prodrug whose active entity is CT7758 [1].
|
|
Immunopharmacology Comments |
Zaurategrast was designed to reduce α4 integrin-mediated trafficking tof leukocytes into the CNS, as a mechanism to reduce inflammatory damage in the brains of MS patients. |